Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2012
05/09/2012CN101601699B Kostelezkya virginica saponin preparation process and application
05/09/2012CN101549036B Effective component of morinda officinalis and preparation method thereof
05/09/2012CN101514229B Human interferon alpha derivative and polyethylene glycol modified substance thereof
05/09/2012CN101503458B Small molecule polypeptide for preventing and treating angiogenesis and use thereof
05/09/2012CN101475643B Double single chain antibody strengthened fusion protein dFv-LDP-AE, preparation and use thereof
05/09/2012CN101467996B Use of deuteroporphyrin derivates
05/09/2012CN101433613B Effective component of Chinese dittany bark as well as preparation method and use thereof
05/09/2012CN101371832B Medical use of triacetyl andrographolide as proinflammatory cytokine inhibitor
05/09/2012CN101348482B 3-amido-4-indole maleimide compound, preparation and use thereof
05/09/2012CN101347509B Effective component of Sinomenium acutum and preparation thereof
05/09/2012CN101267821B Use of FLT3 inhibitor and a farnesyl transferase inhibitor in preparing medicine for synergistic modulation of FLT3 kinase
05/09/2012CN101260151B Sea purse blood vessel generation inhibitive factor 1, and application thereof in preparing medicament
05/09/2012CN101213195B Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
05/09/2012CN101198590B Novel pyridine derivative and pyrimidine derivative (3)
05/09/2012CN101146532B Pharmaceutical compounds
05/09/2012CN101072797B Antibody binding EPHB4, inhibiting angiogenesis and tumor growth
05/08/2012US8173786 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173779 Neutralizing human anti-IGFR antibody
05/08/2012US8173778 Antibody to a guanine nucleotide exchange factor
05/08/2012US8173677 Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
05/08/2012US8173663 Dipeptidyl peptidase inhibitors
05/08/2012US8173662 Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
05/08/2012US8173654 Triazolopyridazine compounds
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173606 Sulfated oligosaccharide derivatives
05/08/2012US8173602 Detecting CYP24 expression level as a marker for predisposition to cancer
05/08/2012US8173591 Variants of pigment epithelium derived factor and uses thereof
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173384 Methods for analyzing or processing a heparin sample
05/08/2012US8173141 Immunogenic complexes and methods relating thereto
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies
05/08/2012CA2736104C A method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
05/08/2012CA2631664C 9-membered heterobicyclic compounds as inhibitors of protein kinases
05/08/2012CA2533338C Viral vectors
05/08/2012CA2492153C Production of polyketide fkbp-ligand analogues
05/08/2012CA2473135C Stabilised mrna tumour vaccine
05/08/2012CA2469334C Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/08/2012CA2467449C Lactic acid bacteria and their use for treating and preventing cancer
05/08/2012CA2362264C Cytokine-binding domain
05/08/2012CA2350064C Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/03/2012WO2012058673A2 Enhanced cancer treatment and monitoring using recombinant vectors
05/03/2012WO2012058671A1 Substituted quinazoline and pyrido-pyrimidine derivatives
05/03/2012WO2012058588A2 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012WO2012058529A2 Metalloenzyme inhibitor compounds
05/03/2012WO2012058418A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy
05/03/2012WO2012058392A1 Solid dispersions containing an apoptosis-inducing agent
05/03/2012WO2012058291A2 Methods and compositions for differentiating embryonic stem cells
05/03/2012WO2012058241A2 Methods and compositions for ameliorating pancreatic cancer
05/03/2012WO2012058115A2 Anti-cancer serine hydrolase inhibitory carbamates
05/03/2012WO2012057765A1 Recombinant anti-cd19 monoclonal antibodies
05/03/2012WO2012057697A1 New diagnostic and therapeutic target
05/03/2012WO2012057421A1 Cancer-metastasis suppression by means of increased task-3 potassium channel expression
05/03/2012WO2012057401A1 Iron oxide nanoparticles in which gluconic acid and non-polymerized biological material are introduced as surface modifier, securing improved biocompatibility by optimum introduction of gluconic acid, and composition for diagnosing and treating cancer, containing same
05/03/2012WO2012057328A1 Anti-cdh3 antibody having high internalizing capability
05/03/2012WO2012057315A1 High-affinity anti-cdh3 antibody
05/03/2012WO2012057291A1 Process for production of phenolic polymerizable compound having physiological activity
05/03/2012WO2012057288A1 Novel anti-dr5 antibody
05/03/2012WO2012057262A1 Pyridine derivative and medicinal agent
05/03/2012WO2012056327A2 A method for increasing the replication of oncolytic hsvs in highly resistant tumor cells using mtor pathway and pi3k inhibitors
05/03/2012WO2012056319A1 Sulfonamides for the modulation of pkm2
05/03/2012WO2012056120A1 Use of a modulator of the patched protein for regulating intracellular cholesterol concentration
05/03/2012WO2012056048A1 Treatment of inflammation
05/03/2012WO2012055961A1 Means and methods for treating dlbcl
05/03/2012WO2012055952A1 Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii
05/03/2012WO2012055879A1 Method of treatment by inhibition of baz1b
05/03/2012WO2012055846A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl] methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/03/2012WO2012055568A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012WO2012055466A1 Quinazoline derivatives
05/03/2012WO2012055369A1 Quinazoline derivative and quinazoline complex protein kinase inhibitor for inhibiting multiplication of tumor cells and preparation method thereof
05/03/2012WO2012055346A1 Polymorph of n-(6-(4-chlorophenoxy)hexyl)-n'-cyano-n''-(4-pyridyl)guanidine, and preparation therefor and use thereof
05/03/2012WO2012055205A1 Pegylated recombinant consensus interferon variant conjugate and preparation mehtod and uses thereof
05/03/2012WO2012055163A1 Letrozole type i crystal and preparation method thereof
05/03/2012WO2012055083A1 Fusion protein comprising vegi, pharmaceutical composition and use thereof
05/03/2012WO2012055057A1 Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
05/03/2012WO2012055020A1 Thermosensitive liposomes
05/03/2012WO2012054988A1 Seleno-compounds and therapeutic uses thereof
05/03/2012WO2012054978A1 Novel anti-cancer agents
05/03/2012WO2012025762A3 Pure intermediate for preparing letrozole
05/03/2012WO2012019024A3 Her3-binding molecules and immunoconjugates thereof
05/03/2012WO2012018235A3 Method for preparing decitabine with improved yield and purity
05/03/2012WO2012009611A9 Methods and compositions for cancer immunotherapy
05/03/2012WO2012002760A3 Method for treating and diagnosing cancer by using cell-derived microvesicles
05/03/2012WO2011162515A3 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
05/03/2012WO2011159981A3 Lung regeneration using cord blood-derived hematopoietic stem cells
05/03/2012WO2011159100A3 Anti-cancer pharmaceutical composition
05/03/2012WO2011150320A3 Activators of innate immunity
05/03/2012WO2011133983A3 Reishi polysaccharide-based compositions and methods for treatment of cancer
05/03/2012WO2011133795A3 Beta-carbolines as inhibitors of haspin and dyrk kinases
05/03/2012WO2011130753A3 Functionalized nano- and micro-materials for medical therapies
05/03/2012WO2011115513A9 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
05/03/2012WO2011041336A3 Treating notch1-antagonist-resistant cancer (s) using notch3 antagonists
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108667 Hydroxy ceramides and analogs thereof and their use for preventing or treating cancer
05/03/2012US20120108666 Treatment of Cell Proliferative Disorders
05/03/2012US20120108656 Use of microrna-199b-5p in medical and diagnostic field
05/03/2012US20120108655 Methods of Diagnosing and Treating Carcinomas
05/03/2012US20120108641 Antitumor combination including ave8062 and sorafenib
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 2211